United States. Securities and Exchange Commission
Nuveen All Cap Energy Mlp Opportunities Fund has filed its annual report with the Securities and Exchange Commission (SEC), providing a comprehensive update on the company's proxy voting record for the fiscal year ended June 30. The report, submitted in the form of Form N-PX, contains detailed information
United States. Securities and Exchange Commission
Celsion Corp. has fulfilled its regulatory obligations by submitting a Form 4 filing with the U.S. Securities and Exchange Commission (SEC). This filing is a mandatory requirement for companies, as per the guidelines set forth in the Securities Exchange Act of 1934. The submission on August 7, 2015, marks
United States. Securities and Exchange Commission
Zimmer Biomet Holdings, Inc. has filed a SEC filing (Form SC 13G) with the U.S. Securities and Exchange Commission (SEC) on August 7, 2015. The document was posted on August 24, 2015, and pertains to the company's acquisition of securities in the ordinary course of business, without
United States. Securities and Exchange Commission
Southern California Gas Co., a company involved in natural gas transmission, has submitted a registration form to the U.S. Securities and Exchange Commission (SEC). This form, known as Form S-3, is used by companies that meet specific eligibility tests and have reported under the '34 Act for a
United States. Securities and Exchange Commission
Energy Transfer Partners, L.P. (NYSE: ETP), a Delaware limited partnership, has filed a Form 8-K (Current Report) with the Securities and Exchange Commission (SEC) on August 19, 2015. The report includes information about the company's management team holding informational sessions with analysts at the Citi 2015 MLP/
United States. Securities and Exchange Commission
Edwards Lifesciences Corp., a leading global medical technology company, has filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission (SEC) on July 29, 2015. The company's filing, which includes unaudited financial statements, provides a continuing view of the company's financial
United States. Securities and Exchange Commission
U.S. Securities and Exchange Commission (SEC) filings provide critical information for investors and security holders, offering a glimpse into the latest developments within publicly-traded companies. On July 23, 2015, Arrhythmia Research Technology Inc. submitted a Form 8-K filing, detailing three documents and significant corporate changes. This filing marks a
United States. Securities and Exchange Commission
Rhode Island Senator Jack Reed has been a key proponent of a rule that will require publicly traded companies to disclose the pay gap between their chief executive officers (CEOs) and rank-and-file employees. The Securities and Exchange Commission (SEC) has adopted the rule, which is a result of the Dodd-Frank
United States. Securities and Exchange Commission
The Securities and Exchange Commission (SEC) has been grappling with finalizing rules for crowdfunding exemptions under the Jumpstart Our Business Startups Act (JOBS Act) passed in 2012. Meanwhile, state legislatures have taken the initiative to enact crowdfunding exemptions within their state securities laws, with 20 states and the District of
United States. Securities and Exchange Commission
Xenoport Inc., a pharmaceutical company, filed a form 4 with the Securities and Exchange Commission (SEC) on July 15, 2015, disclosing transactions involving shareholders and officers. The SEC filing is a formal document or financial statement submitted by publicly-traded companies to provide transparency on ownership and financial activities. Key Takeaways:
United States. Securities and Exchange Commission
According to the U.S. Securities and Exchange Commission (SEC) filing by Xoma Corp. (Form 4), on July 10, 2015, an insider transaction was submitted. The filing, accessible on the SEC website, provides details about the document filed with this form. The SEC filing is a formal document submitted by
United States. Securities and Exchange Commission
U.S. Securities and Exchange Commission (SEC) filing by Vertex Pharmaceuticals Inc. reveals details about transactions involving directors, officers, or owners of more than 10% of the company's stock. The filing, submitted on July 7, 2015, discloses information on purchases and sales of equity securities. As a publicly-traded
